Community Studies of Long Acting Buprenorphine (CoLAB) (CoLAB)
An Open-label, Multicentre, Single-arm Trial of Monthly Injections of Depot Buprenorphine in People With Opioid Dependence
Sponsor: The University of New South Wales
A PHASE3 clinical study on Opioid Dependence, this trial is ongoing. The trial is conducted by The University of New South Wales and has accumulated 11 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Apr 2022 — Jul 2024 [monthly]
Unknown Status PHASE3
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Apr 2022 [monthly]
Active Not Recruiting PHASE3
-
Apr 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE3
▶ Show 6 earlier versions
-
Dec 2019 — Apr 2020 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Sep 2019 — Dec 2019 [monthly]
Recruiting PHASE3
-
Aug 2019 — Sep 2019 [monthly]
Recruiting PHASE3
-
Jun 2019 — Aug 2019 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
May 2019 — Jun 2019 [monthly]
Not Yet Recruiting PHASE3
-
Feb 2019 — May 2019 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- The University of New South Wales
For direct contact, visit the study record on ClinicalTrials.gov .